switching from semaglutide to tirzepatide Tirzepatide: A Provider's Guide Switching GLP-1 Agonists for MAXIMUM
Description
doi: 10.1038/nature13835 33 AbellNSDeGorterMKGloudemansMJGreenwaldESmithKSHeZet al
You can read the full article at Achieving and maintaining glycemic targets is pivotal for managing type 2 diabetes
The drug effectively co-opts albumins stability and longevity
The gradual escalation gives your body time to adjust and reduces gastrointestinal side effects that are most common during dose changes
They enhance glycemic control by stimulating insulin secretion and suppressing glucagon production in response to energy intake (Neumiller, 2015)
